Diagnosis of ovarian dysgerminoma during pregnancy;Diagnóstico de disgerminoma ovariano durante a gestação

Revista da Associacao Medica Brasileira

Volumn 56, Issue 5, 2010, Pages 517-519

  Gauza, José Eduardo ^a   Reberti, Ademir Garcia ^a,b   Silva, Jean Carl ^a,b   Pope, Leonora Zozula Blind ^a,b   dos Santos, João Cesar da Rocha ^a   Quintana, Silvana Maria ^a,c  

^a Hospital Dona Helena   (Brazil)

^b UNIVERSITY OF JOINVILLE REGION   (Brazil)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 78650499671     PISSN: 01044230     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0104-42302010000500009     Document Type: Article

References (26)

1. Ladis SH, Murray T, Bolden S, Wingo PA. Cancer statistics. CA Cancer J Clin. 1998;48:6-25.
2. Duska L, Bicher A. Câncer de ovário. In: Lambrou NC, Morse AN, Wallach E. Manual de ginecologia e obstetrícia do Johns Hopkins. Porto Alegre: Artmed; 1999. p.431-50.
3. Thimble EL. The NIH Consenus Conference on ovarian cancer: screening, treatment and follow-up. Gynecol Oncol. 1994;55:51-3.
4. Palenzuela G, Martin E, Meunier A, Beuzeboc P, Laurence V, Orbach D, et al. Comprehensive staging allows for excellent outcome in patients with localized malignant germ cell tumor of the ovary. Ann.Surg. 2008;248:836-41.
5. Nguyen HN, Averette HE, Janicek M. Ovarian carcinoma: a review of the significance of familial risk factors and the role of prophylactic oophorectocmy in cancer prevention. Cancer. 1994;74:545-55.
6. Zganjer M, Cizmic A, Stepan J, Butkovic D, Zupancic B, Bartolek F. Ovarian dysgerminoma and acute abdomen. Bratisl.Lek.Listy. 2006;107:253-5.
7. Topuz S, Iyibozkurt AC, Akhan SE, Keskin N, Yavuz E, Salihoglu Y, et al. Malignant germ cell tumors of the ovary: a review of 41 cases and risk factors for recurrence. Eur.J.Gynaecol.Oncol. 2008;29:635-7.
8. Desirotte G, Pintiaux A, Foidart JM, Nisolle M. Four clinical cases of dysgerminoma. Rev Med Liege. 2008;63:523-7.
9. Guillem V, Poveda A. Germ cell tumours of the ovary. Clin Transl Oncol. 2007;9:237-43.
10. Hibi M, Hara F, Tomishige H, Nishida Y, Kato T, Okumura N, et al. 1,25-dihydroxyvitamin D-mediated hypercalcemia in ovarian dysgerminoma. Pediatr Hematol Oncol. 2008;25:73-8.
11. Ishibashi M, Nakayama K, Oride A, Yeasmin S, Katagiri A, Iida K, Nakayama N, Miyazaki K. [A case of PEP(BEP)-resistant ovarian dysgerminoma successfully treated by VeIP therapy]. Gan To Kagaku Ryoho. 2009;36:513-7.
12. Cho MY, Kim HS, Eng C, Kim DS, Kang SJ, Eom M, Yi SY, Bronner MP. First report of ovarian dysgerminoma in Cowden syndrome with germline PTEN mutation and PTEN-related 10q loss of tumor heterozygosity. Am J Surg Pathol. 2008;32:1258-64.
13. Koksal Y, Caliskan U, Ucar C, Yurtcu M, Artac H, Ilerisoy-Yakut Z, et al. Dysgerminoma in a child with ataxia-telangiectasia. Pediatr Hematol Oncol. 2007;24:431-6.
14. Nisolle M, Kridelka F, Fridman V, Claudot A, Lorquet S, Foidart JM. A bilateral dysgerminoma: a rare presentation of the Swyer syndrome. Rev Med Liege. 2005;60:703-6.
15. Namavar-Jahromi B, Mohit M, Kumar PV. Familial dysgerminoma associated with 46, XX pure gonadal dysgenesis. Saudi Med J. 2005; 26:872-4.
16. Rouzier C, Soler C, Hofman P, Brennetot C, Bieth E, Pedeutour F. Ovarian dysgerminoma and Apert syndrome. Pediatr Blood Cancer. 2008;50:696-8.
17. Satge D, Honore L, Sasco AJ, Vekemans M, Chompret A, Rethore MO. An ovarian dysgerminoma in Down syndrome. Hypothesis about the association. Int J Gynecol Cancer. 2006;16(Suppl 1):375-9.
18. Evans KN, Taylor H, Zehnder D, Kilby MD, Bulmer JN, Shah F, et al. Increased expression of 25-hydroxyvitamin D-1alpha-hydroxylase in dysgerminomas: a novel form of humoral hypercalcemia of malignancy. Am J Pathol. 2004;165:807-13.
19. Matthew R, Christopher O, Philippa S. Severe malignancy-associated hypercalcemia in dysgerminoma. Pediatr Blood Cancer. 2006;47:621-3.
20. Fitzgerald SD, Duncan AE, Tabaka C, Garner MM, Dieter A, Kiupel M. Ovarian dysgerminomas in two mountain chicken frogs (Leptodactylus fallax). J Zoo Wildl Med. 2007;38:150-3.
21. Harland S, Smith C, Mogg T, Horadagoda N, Dart A. Surgical resection of a dysgerminoma in a mare. Aust Vet J. 2009;87:110-2.
22. Pauls K, Wardelmann E, Merkelbach-Bruse S, Buttner R, Zhou H. c-KIT codon 816 mutation in a recurrent and metastatic dysgerminoma of a 14-year-old girl: case study. Virchows Arch. 2004;445:651-4.
23. Ramirez TN, Basavilvazo Rodriguez MA, Tellez MA, Robles RG, Lemus RR, et al. Clinical experience with chemotherapy of the malignant tumor of germinal cells (dysgerminoma) of the ovary. Ginecol Obstet Mex. 2004;72:500-7.
24. Patterson DM, Murugaesu N, Holden L, Seckl MJ, Rustin GJ. A review of the close surveillance policy for stage I female germ cell tumors of the ovary and other sites. Int J Gynecol Cancer. 2008;18:43-50.
25. Roth LM, Talerman A. Recent advances in the pathology and classification of ovarian germ cell tumors. Int J Gynecol Pathol. 2006;25:305-20.
26. Cunningham FG, Leveno KJ, Bloom SL, Hauth JC, Rouse DJ, Spong CY, editors. Williams obstetrics. 22nd ed. New York (NY): Mc Graw-Hill; 2005.